Skip to main content
Sitemap
About
About INHN
Towards education
Central Office (Cordoba Unit)
INHN Publisher
Programs
Courses
Copyright Policy
How to cite INHN
Website Table of Contents
Last Uploads
Privacy Policy
Search
INHN Legacy website
INHN Projects
Dictionary
Drugs
Photos
Profiles
Interviews with pioneers
Controversies
Discoveries
Books
Biographies
Perspectives
Archives
Ebooks
Collated
Multilingual Project
INHN Publisher
INHN 2013. Edited by Peter R. Martin
Treating the Brain: An Odyssey. By Barry Blackwell. Foreword by Edward Shorter
Enhancer Sensitive Brain Regulations and Synthetic Enhancers (Selegiline, BPAP) Which Counteract the Regressive Effects of Brain Aging By Joseph Knoll
Thomas A. Ban: Lithium in Psychiatry in Historical Perspective
François Ferrero: Psychiatry and Antipsychiatry: Inquiry into the Geneva 1980s’ Psychiatry Crisis.
Johan Schioldann: History of the Introduction of Lithium into Medicine and Psychiatry
Peter R. Martin: Historical Vocabulary of Addiction
Contact
You are here:
INHN
About
Central Office (Cordoba Unit)
EDUCATION
Thomas A. Ban Neuropsychopharmacology in Historical Perspective - Education in the Field in the Post-Neuropsychopharmacology Era
Dementia Differential Diagnosis 1991 : Conceptual Development
About INHN
Towards education
Central Office (Cordoba Unit)
INHN
Membership
Happy New Year
Carlos Morra: Central Office
Administrative Unit by Leon S. Morra
Carlos Morra: Chronological list of essential publications
Carlos Morra: Guide for Authors
Thomas A. Ban: Recommended additions
ADMINISTRATIVE UNIT
EDUCATION
Thomas A. Ban Neuropsychopharmacology in Historical Perspective - Education in the Field in the Post-Neuropsychopharmacology Era
Bulletin 1: Educational Series 2. Jacques-Joseph Moreau de Tours.
Bulletin 2 : Educational Series 2.Prologue
Bulletin 3 : Educational Series 2. Vignette 1 Overview of the series: An Oral History of Neuropsychopharmacology
Bulletin 4 : Educational Series 2. Chapter 1: John Dalton’s atomic theory and drugs in psychiatry in the 19th century
Educational Series 2. Bulletin 5. Vignette 2: Sedatives in the second part of the 19th century
Educational Series 2. Bulletin 6, Chapter 2: From William Cullen’s “neuroses” to Johann Christian Reil’s “psychiaterie”
Educational Series 2. Bulletin 7, Vignette 3: Classifications of insanity in the late 18th and early 19th century
Educational Series 2. Bulletin 8, Chapter 3: Substances with an effect on consciousness
Educational Series 2. Bulletin 9 Vignette 4 :The isolation of morphine
Bulletin 10 : Reflexes of the brain
Bulletin 11 : Sechenov’s re-evaluation of mental faculties and the brain
Bulletin 12 : Bayle’s discovery and the re-evaluation of the concept of dementia
Bulletin 13 : Louis Sokoloff Autobiography – Regional mapping and imaging of the nervous system
Bulletin 14 : Joseph J. Schildkraut: Autobiography – The catecholamine hypothesis before and thereafter
Bulletin 15 : Alfred Pletscher Autobiography – On the Eve of the Birth of the Neurotransmitter Era in Biological Psychiatry
Bulletin 16 : Leo E. Hollister’s Interview of Julius Axelrod – The Uptake of Neurotransmitters and Psychoactive Drugs
Bulletin 17 : Thomas A. Ban’s Interview of Irwin J. Kopin – Metabolic disposition of catecholamines
Bulletin 18 : Thomas A. Ban’s Interview of Philip B. Bradley – Recording Electrical Activity from Cerebral Cortex and Subcortical Structures in Conscious Cats
Bulletin 19 : From Conditioning and Psychiatry to Psychopharmacology*
Bulletin 20 : Conditioning and Psychiatry
Bulletin 21 : Psychopharmacology
Bulletin 22 : Physiological patterns: A diagnostic test procedure based on the conditional reflex method
Bulletin 23 : Clinical pharmacology of psychotropic drugs
Bulletin 24 : Methodology and pitfalls in clinical testing of psychopharmacological drugs
Bulletin 25 : Toxicity and Adverse Reaction Studies with Neuroleptics and Antidepressants
Bulletin 26 : The effect of phenothiazines on the electrocardiogram
Bulletin 27 : Skin pigmentation, a rare side effect of chlorpromazine
Bulletin 28 : Ernst Feuchtersleben’s separation of psychosis from neurosis
Bulletin 29 : Wilhelm Griesinger and Unitary Psychosis (Einheitpsychose)
Bulletin 30 : Towards Neuropsychopharmacology in 1957
Bulletin 31 : Fifty years CINP
Bulletin 32 : Fifty years ACNP
Bulletin 33 : Starting Up (Volume One): 1. The Interviews
Bulletin 34 : Starting Up (Volume One): 2. Psychiatry
Bulletin 35 : Starting Up (Volume One): 3. Drugs
Bulletin 36 : Starting Up (Volume One): 4. Pharmacology
Bulletin 37 : Starting Up (Volume One): 5. Interviewees
Bulletin 38 : Neurophysiology (Volume Two): 1. Early Development
Bulletin 39 : Neurophysiology (Volume Two): 2. Interviewees Contributions
Bulletin 40 : Neuropharmacology (Volume Three): 1. Neurotransmitters
Bulletin 41 : Neuropharmacology (Volume Three): 2. Psychotropic drugs
Bulletin 42 : Neuropharmacology (Volume Three): 3a. Contributions of Interviewees
Bulletin 43 : Neuropharmacology (Volume Three): 3b. Contributions of Interviewees
Bulletin 44 : Psychopharmacology (Volume Four): 1. Clinical methodology
Bulletin 45 : Psychopharmacology (Volume Four): 2a. Contributions of Interviewees
Bulletin 46 : Psychopharmacology (Volume Four): 2b. Contributions of Interviewees
Bulletin 47 : Psychopharmacology (Volume Four): 2c. Contributions of Interviewees
Bulletin 48 : Neuropsychopharmacology (Volume Five): 1.Model Psychosis
Bulletin 49 : Neuropsychopharmacology (Volume Five): 2. Psychotoxic metabolites
Bulletin 50 : Neuropsychopharmacology (Volume Five): 3. Psychopharmacology of Schizophrenia; Psychopharmacology of Depression; Endocrine Measures
Bulletin 51 : Neuropsychopharmacology (Volume Five): 4a. Contributions of Interviewees
Bulletin 52 : Neuropsychopharmacology (Volume Five): 4b. Contributions of Interviewees
Bulletin 53 : Neuropsychopharmacology (Volume Five): 4c. Contributions of Interviewees
Bulletin 54 : Addiction (Volume Six): 1. Addiction Psychiatry
Bulletin 55 : Addiction (Volume Six): 2. Substances of abuse
Bulletin 56 : Addiction (Volume Six): 3. Conditioning and addiction
Bulletin 57 : Addiction (Volume Six): 4a. Contributions of interviewees
Bulletin 58 : Addiction (Volume Six): 4b. Contributions of interviewees.
Bulletin 59 : Special Areas (Volume Seven): 1. Child Psychiatry
Bulletin 60 : Special Areas (Volume Seven): 2. Geriatric Psychiatry
Bulletin 61 : Special Areas (Volume Seven): 3. Psychiatric diagnosis
Bulletin 62 : Special Areas (Volume Seven): 4. Pharmacokinetics
Bulletin 63 : Special Areas (Volume Seven): 5a. Contributions of Interviewees.
Bulletin 64 : Special Areas (Volume Seven): 5b. Contributions of Interviewees
Bulletin 65 : Special Areas (Volume Seven): 5c. Contributions of Interviewees
Bulletin 66 : Diverse Topics (Volume Eight): 1. Regulation, Ethics, Marketing and Education, Conflict of Interest
Bulletin 67 : Diverse Topics (Volume Eight): 2a. Interviewees Contributions
Bulletin 68 : Diverse Topics (Volume Eight): 2b. Interviewees Contributions
Bulletin 69 : Update (Volume Nine): 1. Pharmacogenetics and Genetics and Neuropsychopharmacology
Bulletin 70 : Update (Volume Nine): 2. Psychopathology and Nosology
Bulletin 71 : Update (Volume Nine): 3a. Interviewee’s Contributions
Bulletin 72 : Update (Volume 9) 3b. Interviewees contributions
Bulletin 73 : Volume 10. Postscript
Bulletin 74 : An Overview of Developments in Psychopharmacology and Neuropsychopharmacology
Bulletin 75 : The confounding of education with marketing
Bulletin 76 : Towards a genetic era in neuropsychopharmacology
Bulletin 77 : The CODE System
Bulletin 78 : Nosologic Homotyping
Collated Bulletin 1: RDoC in Historical Perspective.
Collated Bulletin 2 : Neuropsychopharmacology and the Forgotten Language of Psychiatry
Collated Bulletin 3 : In Historical Perspective: Peralta, Cuesta and their associate’s findings on the highest familiality of Leonhard’s Classification in Polynosologic Study
Collated Bulletin 4: Thomas A. Ban: The Birth of a Medical Discipline: Psychiatry
Collated Bulletin 5: Thomas A. Ban: Conflict of Interest in Neuropsychopharmacology. Marketing vs. Education.
Collated Bulletin 6: Edward Shorter: The QT interval and the Mellaril story
Collated Bulletin 7 : Thomas A. Ban: The Wernicke – Kleist – Leonhard Tradition with Special Reference to Mania, Melancholia and Manic – Depressive Psychosis
Collated Bulletin 8 : Thomas A. Ban: The Birth of Drug Industry and Drugs with An Effect On Behavior
Collated Bulletin 9 : Thomas A. Ban: From Melancholia to Depression
Collated Bulletin 10 : Thomas A. Ban: The Year 1845
Collated Bulletin 11 : Joseph Knoll: The discovery of monoamine oxidase (MAO) enzymes
Collated Bulletin 12 : Samuel Gershon: Events and Memories
Collated Bulletin 13 : Paul Devenyi: Addictions are not treatable diseases and Pharmacotherapy of addiction not a success story.
Collated Bulletin 14 : Janos Radó: The use of modern antidiuretic agents in the treatment of permanent lithium-induced nephrogenic diabetes insipidus
Collated Bulletin 15 : Per Bech: Clinical Psychometrics
Collated Bulletin 16 : Martin M. Katz: Onset of clinical effects of antidepressants
Collated Bulletin 17 : Martin M. Katz: Depression and Drugs, a monograph and Multivantaged vs Conventional Assessment, an essay
Collated Bulletin 18 : Per Bech: Measurement-based care in mental disorders (New York: Springer; 2016) Foreword and Review
Collated Bulletin 19 : Donald F. Klein and John Davis: Diagnosis and Drug Treatment of Mental Disorders and Thomas A. Ban: Psychopharmacology in 1969
Collated Bulletin 20 : Thomas A. Ban: Schizophrenia in the Early 1970s
Collated Bulletin 21 : Thomas A. Ban, Marcelo Cetkovich-Bakmas, Ernst Franzek and Hector Warnes: Carl Wernicke’s “elementary symptoms” and “sejunction hypothesis”
Collated Bulletin 22 : Martin M. Katz: Clinical Trials of Antidepressants: How Changing the Model Can Uncover New, More Effective Molecules
Collated Bulletin 23 : Joseph Knoll: From the Theory of Active Reflexes to a Neurochemical Concept of Innate and Acquired Drive
Collated Bulletin 24 : Ildiko Miklya: The History of Selegiline (-) Deprenyl the First Selective Inhibitor of B-Type Monoamine Oxidase and the First Synthetic Catecholaminergic Enhancer Substance
Collated Bulletin 25 : Joseph Knoll: The Discovery of the Enhancer Regulation in the Mammalian Brain and the Development of the Synthetic Enhancer Substances
Collated Bulletin 26 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology: Julius Axelrod, Frank Ayd, Frank Berger, Hans Berger and Hermann Blaschko
Collated Bulletin 27 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Charles Bradley, Philip B. Bradley, Bernard B. Brodie, John Cade and John Delay
Collated Bulletin 28 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Edmundo Fischer, W. Horsley Gantt, Turan M. Itil, Hitoshi Itoh and Paul Kielholz
Collated Bulletin 29 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Nathan S. Kline, Roland Kuhn, Heinz E. Lehmann, Laszlo Meduna and Dionisio Nieto Gomez
Collated Bulletin 30 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Alfred Pletscher, Juri Saarma, Sydney Spector, Leo Sternbach, Edward Trautner and Joseph Wo
Collated Bulletin 31 : Thomas A. Ban: Lithium. 1. Discovery of its therapeutic effect in psychiatry. Johan Schioldann, William T. Hammond and Carl Lange
Collated Bulletin 32 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective. 2. Introduction into treatment in psychiatry. Samuel Gershon: Profiles of John Cade and Edward Trautner
Collated Bulletin 33 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective. 3. Early Years. Samuel Gershon: First-Hand Accounts
Collated Bulletin 34 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective
Collated Bulletin 35 : Thomas A. Ban: Lithium. 4. Controversy. Barry Blackwell vs Paul Grof and Jules Angst
Collated Bulletin 36 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective 5. Turning point. Paul Grof and Johan Schioldann
Collated Bulletin 37 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective 6. Action. Janusz Rybakowski
Collated Bulletin 38 : Thomas A. Ban: 7. Diagnosis
Collated Bulletin 39 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective Dedication and Preface
Collated Bulletin 40 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective.
Collated Bulletin 41 : Peter R. Martin. Volume 1. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Thomas A. Ban
Collated Bulletin 42 : Peter R. Martin. Volume 2. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Leo E. Hollister
Collated Bulletin 43 : Peter R. Martin. Volume 2. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by William E. Bunney, Jr.
Lehmann Collection 1 : Charles E. Cahn’s interview of Heinz E. Lehmann
Lehmann Collection 2 : William E. Bunney’s interview of Heinz E. Lehmann
Lehmann Collection 3 : Heinz Edgar Lehmann by Barry Blackwell
Lehmann Collection 4 : Heinz Lehmann and Douglas Hospital by Charles C. Cahn
Lehmann Collection 5 : Heinz Edgar Lehmann’s research profile by Antonio E. Nardi.
Lehmann Collection 6 : Heinz E. Lehmann by Edward Shorter.
Lehmann Collection 7 : Per Bech’s comment on Heinz E. Lehmann*
Lehmann Collection 8 : Paul Grof’s comment on Heinz E. Lehmann. A few personal recollections
Lehmann Collection 9 : Irwin J. Kopin’s comment on Heinz E. Lehmann.
Lehmann Collection 10 : Mary and Philip Seeman's comment
Lehmann Collection 11 : A Tribute to Heinz Edgar Lehmann by Hector Warnes.
Lehmann Collection 12 : Heinz Edgar Lehmann: Publication
Lehmann Collection 13 : Thomas A. Ban: My Personal Notes on Heinz Lehmann
Lehmann Collection 14 : Thomas A. Ban: Heinz E. Lehmann and Psychopharmacology
Lehmann Collection 15 : Thomas A. Ban: Towards a clinical methodology for neuropsychological research
Lehmann Collection 16 : Heinz Edgar Lehmann
Lehmann Collection 17 : Heinz E. Lehmann: What is wrong with getting old?
Lehmann Collection 18 : Heinz E. Lehmann: Dreaming about Mental Health
Lehmann Collection 19: Heinz E. Lehmann: Alcoholism, aggression and androgen function. Discussion of paper by Jack Mendelson
Lehmann Collection 20: Heinz E. Lehmann: Perspectives in Psychosurgery
Lehmann Collection 21 : Heinz E. Lehmann: Discussion of the paper by Prof. P. Pichot: The Treatment of Depression
Lehmann Collection 22 : Heinz E. Lehmann: Harlem Valley Revisited
Lehmann Collection 23 : Heinz E. Lehmann: Chlorpromazine: The Story of Phenothiazine Derivatives, Their Clinical Indications, the Incidence and Management of Untoward Effects and a Proposed Rational for Its Action
Lehmann Collection 24 : Heinz E. Lehmann: The Anatomy of Research Funding
Lehmann Collection 25 : Program of Academic morning in honor of Dr. Heinz Lehmann
Lehmann Collection 26 : Heinz E. Lehmann: Types and Characteristics of Objective Measures of Psychopathology
Classification of Functional Psychoses 1 : Preface and Recommended Reading
Classification of Functional Psychoses 2 : Introduction
Classification of Functional Psychoses 3 : ICD-9 and DSM-III
Classification of Functional Psychoses 4: Classification of Mental Disorders and Psychopharmacology – Diagnostic Criteria for Research
Classification of Functional Psychoses 5: The KDK Budapest
Classification of Functional Psychoses 6: One- and Two-Dimensional Diagnoses
Classification of Functional Psychoses 7: Delusional Development and Delusional Psychoses
Classification of Functional Psychoses 8: Bayle’s Unitary Concept of Psychosis and Endogenous Psychoses
Classification of Functional Psychoses 9: Affective Psychosis
Classification of Functional Psychoses 10: Empirical and Pragmatic Classifications of Depression
Classification of Functional Psychoses 11: Schizophrenic Psychoses
Classification of Functional Psychoses 12: Cycloid Psychoses
Classification of Functional Psychoses 13: Conclusions
Classification of Functional Psychoses 14: References
Delcir da Costa’s comment on collating document
Dementia Differential Diagnosis 1991 : Contents
Dementia Differential Diagnosis 1991 : Conceptual Development
(current)
Dementia Differential Diagnosis 1991 : Dementing Illnesses
Dementia Differential Diagnosis 1991 : Modified Concept
Dementia Differential Diagnosis 1991 : References
Methodology pitfalls of clinical testing of psychopharmaceutical
Mental health (Psychiatry) and pharmaceuticals in a historical perspective
Nosology in the teaching of psychiatry. Introduction
Towards a clinical methodology for neuropsychopharmacological research
Selective Drugs Versus Heterogeneous Diagnoses. Towards a New Methodology in Psychopharmacologic Research
Per Bech: Members of the International Committee for the Prevention and Treatment of Depression in the mid-1980s
Per Bech and Wolfgang Rutz: The Story of the International Committee for the Prevention and Treatment of Depression
Amara McLaughlin-Harris: The Legal History of Psychoactive Drugs
Carlos Morra: An Educational Model in Psychiatry
Carlos Morra and Ernst Franzek: Psychopathological Symptoms
Carlos Morra and Mateo Kreiker: Psychopathology
INHN Publisher
Programs
Courses
Copyright Policy
How to cite INHN
Website Table of Contents
Last Uploads
Privacy Policy
Thomas A. Ban: Neuropsychopharmacology in Historical Perspective. Dementia Differential Diagnosis
Conceptual Development
CLICK HERE TO OPEN THE DOCUMENTS
August 12, 2021
